Literature DB >> 8838925

Alopecia areata: immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors.

I Ghersetich1, G Campanile, T Lotti.   

Abstract

BACKGROUND: Alopecia areata (AA) is a noncicatricial alopecia with still unknown pathogenesis, but increasing evidence suggests that an immunologic process might be responsible for the disease.
MATERIALS AND METHODS: Nineteen patients with AA were studied with ten of them in the progressive phase of the disease and nine in the stabilized phase. Biopsies of both affected and unaffected skin were taken. For immunohistochemistry, monoclonal antibodies directed against CD3, CD4, CD8, CD10a, CD36, and HLA-DR antigens, were used, as well as antibodies directed against adhesion molecules ICAM-1, ELAM-1 and LFA-1. For electron microscopy (EM), specimens were fixed in glutaraldehyde-sodium cacodylate buffer, post-fixed in osmium tetroxide, and stained with uranyl acetate. For statistical analysis, sections from involved and uninvolved skin of each patient for each antibody, the sign test, Fisher's F-test, and the Tukey-Kramer test were used.
RESULTS: There was a rich infiltrate of CD4+ cells and CD1a+ cells, particularly in the perivascular zone of both unaffected and affected skin (here in the perivascular and in the peribulbar zone) in the progressive phase of AA. In the stabilized phase the infiltrate was scant, both in unaffected and affected skin and limited to the peribulbar area. Receptors of adhesion molecules (ICAM-2, ELAM-1, LFA-1) were strongly expressed, mainly at the microvascular level in both unaffected and affected skin in the progressive phase, but were only weakly or not at all expressed in the stabilized phase, again in unaffected and affected skin. Ultrastructural data confirmed the immunohistochemical findings and showed close contacts between infiltrating lymphocytes and Langerhans'-lineage cells mainly in the progressive phase.
CONCLUSIONS: Our results suggest that: 1) an immunologic process, apparently carried out by CD4+ lymphocytes and by dendritic CD1a+ and CD36+ cells, may play a key role at least in the early phase of the disease involving primarily microvessels and later on the bulbar area; 2) the expression of adhesion molecule receptors is involved at the beginning of the disease by mediating the adherence of leukocytes to endothelial cells and subsequent trafficking into the dermis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838925     DOI: 10.1111/j.1365-4362.1996.tb01611.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Review.

Authors:  Gloria Taliani; Elisa Biliotti
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-08

Review 2.  Genetic basis of alopecia areata: a roadmap for translational research.

Authors:  Ali Jabbari; Lynn Petukhova; Rita M Cabral; Raphael Clynes; Angela M Christiano
Journal:  Dermatol Clin       Date:  2012-10-23       Impact factor: 3.478

3.  Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.

Authors:  M Zöller; P Freyschmidt-Paul; M Vitacolonna; K J McElwee; S Hummel; R Hoffmann
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

4.  Immunohistochemistry: relevance in dermatology.

Authors:  Aparna Palit; Arun C Inamadar
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

5.  The role of selectins in alopecia areata.

Authors:  Wiesława Sudnik; Aleksandra Dańczak-Pazdrowska; Wojciech Silny; Agnieszka Osmola-Mańkowska; Jakub Pazdrowski; Adriana Polańska
Journal:  Postepy Dermatol Alergol       Date:  2015-02-03       Impact factor: 1.837

6.  Angiotensin converting enzyme activity in alopecia areata.

Authors:  Mohammad Reza Namazi; Armaghan Ashraf; Farhad Handjani; Ebrahim Eftekhar; Amir Kalafi
Journal:  Enzyme Res       Date:  2014-10-01

7.  Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens.

Authors:  Danuta Nowicka; Joanna Maj; Alina Jankowska-Konsur; Anita Hryncewicz-Gwóźdź
Journal:  Postepy Dermatol Alergol       Date:  2018-11-08       Impact factor: 1.837

8.  308-nm Excimer Lamp for the Treatment of Alopecia Areata: Clinical Trial on 16 Cases.

Authors:  Akiko Ohtsuki; Toshio Hasegawa; Etsuko Komiyama; Atsushi Takagi; Junko Kawasaki; Shigaku Ikeda
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.